Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01020669 · ClinicalTrials.gov registry record

Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
24
Enrollment target

NCT01020669: Completed study, sponsored by National Institute on Drug Abuse (NIDA).

NCT01020669 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01020669 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

Background: \- Recent research has suggested that prenatal exposure to drugs may affect specific brain processes, including working memory, stress response, and decision making. However, most of the research on the effects of prenatal drug exposure in humans has been conducted early in life, and very little is known about effects of prenatal drug exposure during the crucial brain development period that takes place during puberty and adolescence. The biological and psychological changes associated with puberty may increase adolescents' sensitivity to prenatal substance exposure. Researchers are interested in using functional magnetic resonance imaging (fMRI) scans to study brain function and learn more about the effects of prenatal drug exposure on adolescents. Objectives: \- To examine the effects of prenatal substance exposure on working memory, decision making, and normal brain activity in adolescents. Eligibility: \- Adolescents between 12 and 17 years of age who are enrolled in a larger follow-up study of children exposed to drugs in utero. Design: * The study will involve a single outpatient session with two fMRI scans that will test working memory and decision-making processes. * Participants will have brief medical history, a physical examination, and a urine test for drugs of abuse. * Participants will then be trained on the working memory and decision-making tasks before having an initial MRI scan to provide a baseline reading. * The fMRI scans will take 40 to 45 minutes each, and participants will have break in between as needed.

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2009-10-16
Est. Completion 2011-07-13

What the finished NCT01020669 record still lists

NCT01020669 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01020669 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01020669 about?

NCT01020669 is a clinical study titled "Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development". Background: \- Recent research has suggested that prenatal exposure to drugs may affect specific brain processes, including working memory, stress response, and decision making. However, most of the research on the effects of prenatal drug exposure in humans has been conducted early in life, and ve...

What is the current status of trial NCT01020669?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2009-10-16. Estimated completion is 2011-07-13.

Who is sponsoring clinical trial NCT01020669?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01020669, the US trial registry maintained by the National Library of Medicine. NCT01020669 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.